Connective tissue activation. VI. The effects of cylic nucleotides on human synovial cells in vitro.
D000249:Adenosine Monophosphate / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology; D002087:Butyrates; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000494:pharmacology; D006152:Cyclic GMP / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D003864:Depression, Chemical; D004357:Drug Synergism; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006019:Glycolysis; D006801:Humans; D006820:Hyaluronic Acid / Q000096:biosynthesis*; D006854:Hydrocortisone / Q000494:pharmacology; D007773:Lactates / Q000378:metabolism; D009712:Nucleotides, Cyclic / Q000494:pharmacology*; D010455:Peptides / Q000494:pharmacology; D013268:Stimulation, Chemical; D013583:Synovial Membrane / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D013806:Theophylline / Q000494:pharmacology
D002087:Butyrates; D007773:Lactates; D009712:Nucleotides, Cyclic; D010455:Peptides; D000249:Adenosine Monophosphate; D003994:Bucladesine; D006820:Hyaluronic Acid; D003513:Cycloheximide; D013806:Theophylline; D000242:Cyclic AMP; D006152:Cyclic GMP; D005947:Glucose; D006854:Hydrocortisone